What is the Role of Amikacin in Managing Febrile Neutropenia?
Febrile neutropenia is a common and serious complication in cancer patients, characterized by fever and a low number of neutrophils. Amikacin is often part of the initial empirical antibiotic therapy in febrile neutropenia to cover gram-negative organisms, including Pseudomonas aeruginosa, which are frequent culprits in these infections.